|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | G01N 33/573 | (2006.01) |
| C07K 14/705 | (2006.01) | ||
| C12N 9/16 | (2006.01) | ||
| G01N 33/574 | (2006.01) |
| (11) | Number of the document | 2503338 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12002502.8 |
| Date of filing the European patent application | 2008-10-15 | |
| (97) | Date of publication of the European application | 2012-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-24 |
| (46) | Date of publication of the claims translation | 2015-05-25 |
| (30) | Number | Date | Country code |
| 20070795 | 2007-10-24 | FI |
| (72) |
Jalkanen, Sirpa, FI
Salmi, Marko, FI
Jalkanen, Markku, FR
|
| (73) |
Faron Pharmaceuticals OY,
Tykistökatu 6 B, 20520 Turku,
FI
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CD73 kaip biologinis žymuo, skirtas ligų vystymosi kontrolei ir terapijos efektyvumo įvertinimui |
| CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies |
| Payment date | Validity (years) | Amount | |
| 2023-10-03 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-10-15 |